|
US7060708B2
(en)
*
|
1999-03-10 |
2006-06-13 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
|
US6716452B1
(en)
*
|
2000-08-22 |
2004-04-06 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
|
US8394813B2
(en)
|
2000-11-14 |
2013-03-12 |
Shire Llc |
Active agent delivery systems and methods for protecting and administering active agents
|
|
US7169752B2
(en)
*
|
2003-09-30 |
2007-01-30 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
|
US7338939B2
(en)
*
|
2003-09-30 |
2008-03-04 |
New River Pharmaceuticals Inc. |
Abuse-resistant hydrocodone compounds
|
|
US7375082B2
(en)
*
|
2002-02-22 |
2008-05-20 |
Shire Llc |
Abuse-resistant hydrocodone compounds
|
|
US20060014697A1
(en)
*
|
2001-08-22 |
2006-01-19 |
Travis Mickle |
Pharmaceutical compositions for prevention of overdose or abuse
|
|
US20070066537A1
(en)
*
|
2002-02-22 |
2007-03-22 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
|
US7105486B2
(en)
*
|
2002-02-22 |
2006-09-12 |
New River Pharmaceuticals Inc. |
Abuse-resistant amphetamine compounds
|
|
IL163668A0
(en)
*
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Use of peptide-drug conjugation to reduce inter-subject variability ofdrug serum levels
|
|
US7700561B2
(en)
*
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
IL163667A0
(en)
*
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Novel sustained release pharmaceutical compounds to preventabuse of controlled substances
|
|
US7659253B2
(en)
|
2002-02-22 |
2010-02-09 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
GB0218811D0
(en)
*
|
2002-08-14 |
2002-09-18 |
Cenes Ltd |
Salts of morphine-6-glucuronide
|
|
US8133881B2
(en)
|
2003-01-13 |
2012-03-13 |
Shire Llc |
Carbohydrate conjugates to prevent abuse of controlled substances
|
|
BRPI0410792B8
(pt)
|
2003-05-29 |
2021-05-25 |
New River Pharmaceuticals Inc |
compostos de anfetamina resistentes à dependencia
|
|
NZ546226A
(en)
*
|
2003-09-30 |
2009-03-31 |
Shire Llc |
Oxycodone conjugates for prevention of overdose or abuse
|
|
KR101453107B1
(ko)
*
|
2006-04-21 |
2014-10-27 |
디에스엠 아이피 어셋츠 비.브이. |
오피오이드 수용체 길항제의 용도
|
|
US20080051380A1
(en)
|
2006-08-25 |
2008-02-28 |
Auerbach Alan H |
Methods and compositions for treating cancer
|
|
FR2939436B1
(fr)
*
|
2008-12-10 |
2010-12-17 |
Sanofi Aventis |
Synthese de morphine-6-glucuronide ou de l'un de ses derives
|
|
US8716350B2
(en)
*
|
2010-03-30 |
2014-05-06 |
Algynomics Inc. |
Compositions and methods for the treatment of somatosensory disorders
|
|
WO2011126910A2
(en)
|
2010-03-30 |
2011-10-13 |
Algynomics Inc. |
Compositions and methods for the treatment of somatosensory disorders
|
|
JP5977240B2
(ja)
|
2010-09-21 |
2016-08-24 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ブプレノルフィン類似体
|
|
CN104136031B
(zh)
|
2011-10-26 |
2016-05-04 |
凯姆制药公司 |
氢吗啡酮的苯甲酸缀合物、苯甲酸衍生物缀合物和杂芳基羧酸缀合物、其前药、制备和使用方法
|
|
TW201431842A
(zh)
|
2012-11-09 |
2014-08-16 |
Purdue Pharma Lp |
苯並嗎啡烷類似物及其應用
|
|
JP6317755B2
(ja)
|
2012-12-07 |
2018-04-25 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
オピオイド受容体モジュレーターとしてのブプレノルフィン類似体
|
|
JP6100917B2
(ja)
|
2012-12-14 |
2017-03-22 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ピリドンモルフィナン類似体およびオピオイド受容体に対する生物活性
|
|
TW201434837A
(zh)
|
2012-12-14 |
2014-09-16 |
Purdue Pharma Lp |
螺環嗎啡喃及其用途
|
|
JP6182620B2
(ja)
|
2013-01-31 |
2017-08-16 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ベンゾモルファン類似体およびその使用
|
|
US8969358B2
(en)
|
2013-03-15 |
2015-03-03 |
Purdue Pharma L.P. |
Buprenorphine analogs
|
|
HU231191B1
(hu)
|
2013-04-15 |
2021-08-30 |
Szegedi Tudományegyetem |
Izotóp tartalmú morfin molekulák
|
|
EP3087078B1
(en)
|
2013-12-26 |
2019-05-15 |
Purdue Pharma LP |
7-beta-alkyl analogs of orvinols
|
|
CN106414408A
(zh)
|
2013-12-26 |
2017-02-15 |
普渡制药公司 |
缩合环吗啡喃和其用途
|
|
WO2015097547A1
(en)
|
2013-12-26 |
2015-07-02 |
Purdue Pharma L.P. |
10-substituted morphinan hydantoins
|
|
EP3087079B1
(en)
|
2013-12-26 |
2019-04-03 |
Purdue Pharma LP |
Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
|
|
WO2015097546A1
(en)
|
2013-12-26 |
2015-07-02 |
Purdue Pharma L.P. |
Propellane-based compounds and their use as opioid receptor modulators
|
|
WO2015099863A1
(en)
|
2013-12-27 |
2015-07-02 |
Purdue Pharma L.P. |
6-substituted and 7-substituted morphinan analogs and the use thereof
|
|
WO2015183780A1
(en)
|
2014-05-27 |
2015-12-03 |
Purdue Pharma L.P. |
Spirocyclic morphinans and use thereof
|
|
JP6360915B2
(ja)
|
2014-06-13 |
2018-07-18 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
アザモルフィナン誘導体及びその使用
|
|
RU2683274C2
(ru)
|
2014-12-02 |
2019-03-27 |
Кемфарм, Инк. |
Бензойная кислота, производные бензойной кислоты и конъюгаты гетероарилкарбоновой кислоты и оксиморфона, их пролекарства, способы получения и применение
|
|
MA41125A
(fr)
|
2014-12-05 |
2017-10-10 |
Purdue Pharma Lp |
Dérivés de 6.7-cyclomorphinane et leur utilisation
|
|
ITUB20154996A1
(it)
|
2015-10-27 |
2017-04-27 |
Nobili S P A |
Attrezzatura per l?erogazione di un liquido di trattamento ad una rispettiva coltura o piantagione agricola.
|
|
RS66574B1
(sr)
|
2016-07-29 |
2025-03-31 |
Janssen Pharmaceutica Nv |
Niraparib za upotrebu u postupku lečenja raka prostate
|
|
WO2018125716A1
(en)
|
2017-01-02 |
2018-07-05 |
Purdue Pharma L.P. |
Morphinan derivatives and use thereof
|
|
WO2020012245A1
(en)
|
2018-07-13 |
2020-01-16 |
Alkermes Pharma Ireland Limited |
Thienothiophene-naltrexone prodrugs for long-acting injectable compositions
|
|
US10799496B2
(en)
|
2018-07-13 |
2020-10-13 |
Alkermes Pharma Ireland Limited |
Naphthylenyl compounds for long-acting injectable compositions and related methods
|
|
US10975099B2
(en)
|
2018-11-05 |
2021-04-13 |
Alkermes Pharma Ireland Limited |
Thiophene compounds for long-acting injectable compositions and related methods
|
|
WO2024042226A2
(en)
*
|
2022-08-25 |
2024-02-29 |
Biosynth Gmbh |
Procedure for production of opioid-antagonist-releasing compounds and their use as a medicine
|